查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974024

CRISPR市场分析及至2035年预测：按类型、产品、服务、技术、应用、最终用户、组件、功能和解决方案划分

CRISPR Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 300 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计CRISPR市场规模将从2024年的37亿美元成长到2034年的197亿美元，复合年增长率约为18.2%。 CRISPR市场涵盖与CRISPR-Cas9基因编辑相关的技术和服务，并在基因组学、农业和治疗领域提供创新应用。精准医疗、作物改良和生物技术研究的进步是推动该市场成长的主要因素。研发投入的增加和伦理考量正在塑造市场格局，而监管合规和对智慧财产权的重视则影响市场动态和扩张。

受基因编辑技术进步以及在医疗保健和农业领域应用不断拓展的推动，CRISPR市场正经历强劲成长。在这充满活力的市场环境中，治疗领域凭藉其在治疗遗传疾病和癌症方面的创新潜力，已成为成长最快的细分市场。农业领域也紧随其后，利用CRISPR技术提高作物品质和增强抗虫害能力，进而应对全球粮食安全挑战。在各个细分市场中，体内疗法发挥主导作用，展现出在体内直接提供精准基因编辑解决方案的巨大潜力。体外应用也正在蓬勃发展，尤其是在细胞疗法和再生医学领域，凸显了其变革性潜力。研发活动依然活跃，对CRISPR文库和筛检工具的投资正在推动创新。随着伦理考量和法规结构的不断完善，CRISPR市场可望取得更多突破，并正逐步成为生物技术革命的核心力量。

市场区隔
类型 基因组编辑、基因静默、基因扩增
产品 CRISPR试剂盒、CRISPR文库、CRISPR试剂、CRISPR质体
服务 客製化 CRISPR 服务、基因筛检、细胞株设计
科技 CRISPR-Cas9、CRISPR-Cas12、CRISPR-Cas13
目的 生物医学研究、农业生物技术、工业生物技术、药物研发、诊断、治疗、基因治疗
最终用户 製药公司、生技公司、研究机构、学术机构、受託研究机构
成分 引导RNA、Cas酶、供体DNA模板
功能 基因敲除、基因敲入、基因表现调控
解决方案 现成解决方案，客製化解决方案

市场概况：

CRISPR市场呈现出动态变化的格局，包括市场份额分布、定价策略以及新产品推出数量的激增。人们对基因编辑日益增长的兴趣催生了激烈的竞争环境，各公司不断创新以争取市场份额。定价策略的驱动力在于平衡价格可负担性和最尖端科技。近期发表的新产品在准确性和效率方面均有显着提升，吸引了许多科学研究和治疗应用。这一趋势凸显了市场致力于满足多元化科学需求的努力。 CRISPR市场竞争异常激烈，主要企业透过策略联盟和技术创新争夺主导。北美和欧洲的法规结构在塑造市场走向、确保安全性和有效性方面发挥着至关重要的作用。亚太地区的新兴市场在扶持政策和资金投入的推动下正蓬勃发展。不断变化的监管环境影响企业的市场准入和扩大策略。竞争标竿分析凸显了合规性、创新和策略联盟在维持市场领先地位的重要性。

主要趋势和驱动因素：

由于基因编辑技术的进步和研究活动的日益活跃，CRISPR市场正在快速扩张。其主要趋势包括农业领域应用的不断拓展，CRISPR正被用于培育抗病作物并提高产量。在医疗保健领域，CRISPR正在革新遗传疾病的治疗方式，提供精准高效的解决方案。生技投资的增加也是推动市场成长的重要因素，各公司正积极探索CRISPR技术的创新应用。监管支持和有利的政府政策也促进了市场成长。此外，学术机构与生技公司之间的合作正在加速研发进程。在个人化医疗领域，CRISPR拥有巨大的潜力，能够实现根据个体基因谱量身定制的治疗方案。人们对基于CRISPR的诊断技术也越来越感兴趣，期望能够快速且准确地检测疾病。随着伦理挑战的逐步解决，CRISPR市场凭藉其变革各领域的潜力，预计将持续成长。

压制与挑战：

CRISPR市场目前面临诸多限制和挑战。其中一个突出的限制因素是基因编辑相关的伦理问题，这阻碍了监管部门的核准和社会的接受度。潜在的非预期基因效应加剧了这些担忧，因此需要严格的监测和谨慎的应用。另一个挑战是CRISPR技术的高成本，这可能成为小规模研究机构和发展中地区的障碍。这种经济壁垒限制了技术的普及，并减缓了创新的步伐。此外，围绕CRISPR专利的智慧财产权纠纷造成了法律上的复杂性，并可能阻碍合作研究。该市场也面临一些技术挑战，例如脱靶效应，这会影响基因编辑的精确性。这些技术障碍需要大量的研发工作来确保安全性和有效性。最后，CRISPR技术的快速发展要求研究人员不断接受教育和培训，这使得他们难以跟上技术进步的步伐。

目录

第一章：执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 基因组编辑
    • 基因静默
    • 基因扩增
  • 市场规模及预测：依产品划分
    • CRISPR试剂盒
    • CRISPR 文库
    • CRISPR试剂
    • CRISPR质体
  • 市场规模及预测：依服务划分
    • 客製化CRISPR服务
    • 基因筛检
    • 细胞株工程
  • 市场规模及预测：依技术划分
    • CRISPR-Cas9
    • CRISPR-Cas12
    • CRISPR-Cas13
  • 市场规模及预测：依应用领域划分
    • 生物医学研究
    • 农业生物技术
    • 工业生物技术
    • 药物研发
    • 诊断
    • 治疗
    • 基因治疗
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 生技公司
    • 研究机构
    • 学术机构
    • 受託研究机构
  • 市场规模及预测：依组件划分
    • 引导RNA
    • CAS酶
    • 供体DNA模板
  • 市场规模及预测：依功能划分
    • 基因敲除
    • 基因敲入
    • 基因调控
  • 市场规模及预测：按解决方案划分
    • 现成的解决方案
    • 客製化解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Editas Medicine
  • CRISPR Therapeutics
  • Intellia Therapeutics
  • Caribou Biosciences
  • Mammoth Biosciences
  • Beam Therapeutics
  • Synthego
  • Inscripta
  • Cellecta
  • Horizon Discovery
  • ToolGen
  • Egenesis
  • Graphite Bio
  • Locus Biosciences
  • Poseida Therapeutics

第九章 关于我们

简介目录
Product Code: GIS33751

CRISPR Market is anticipated to expand from $3.7 billion in 2024 to $19.7 billion by 2034, growing at a CAGR of approximately 18.2%. The CRISPR Market encompasses technologies and services related to CRISPR-Cas9 gene editing, offering revolutionary applications in genomics, agriculture, and therapeutics. This market is driven by advancements in precision medicine, crop improvement, and biotechnological research. Increasing investment in R&D and ethical considerations shape the landscape, with a focus on regulatory compliance and intellectual property rights influencing market dynamics and expansion.

The CRISPR market is experiencing robust growth, fueled by advancements in gene-editing technologies and increasing applications in healthcare and agriculture. Within this dynamic landscape, the therapeutics segment emerges as the top-performing sub-segment, driven by its potential to revolutionize treatment for genetic disorders and cancers. The agricultural sector follows closely, leveraging CRISPR for crop improvement and pest resistance, addressing global food security challenges. Among the sub-segments, in vivo therapeutics leads, showcasing significant promise in delivering precise gene-editing solutions directly within the body. Ex vivo applications are gaining momentum, particularly in cell therapy and regenerative medicine, underscoring their transformative potential. The research and development sector continues to thrive, with investments in CRISPR libraries and screening tools fueling innovation. As ethical considerations and regulatory frameworks evolve, the CRISPR market anticipates further breakthroughs, positioning it as a pivotal force in the biotechnological revolution.

Market Segmentation
TypeGenome Editing, Gene Silencing, Gene Amplification
ProductCRISPR Kits, CRISPR Libraries, CRISPR Reagents, CRISPR Plasmids
ServicesCustom CRISPR Services, Genetic Screening, Cell Line Engineering
TechnologyCRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13
ApplicationBiomedical Research, Agricultural Biotechnology, Industrial Biotechnology, Drug Development, Diagnostics, Therapeutics, Gene Therapy
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Academic Institutions, Contract Research Organizations
ComponentGuide RNA, Cas Enzymes, Donor DNA Templates
FunctionalityGene Knockout, Gene Knock-in, Gene Regulation
SolutionsOff-the-shelf Solutions, Customized Solutions

Market Snapshot:

The CRISPR market is characterized by a dynamic landscape of market share distribution, pricing strategies, and a surge in new product launches. The growing interest in gene editing has led to a competitive environment where companies are continuously innovating to capture market share. Pricing strategies are influenced by the need to balance affordability with cutting-edge technology. Recent product launches highlight advancements in precision and efficiency, appealing to both research and therapeutic applications. This trend underscores the market's commitment to addressing diverse scientific needs. Competition within the CRISPR market is intense, with key players vying for dominance through strategic partnerships and technological innovation. Regulatory frameworks in North America and Europe play a crucial role in shaping market trajectories, ensuring safety and efficacy. Emerging markets in Asia-Pacific are gaining momentum, driven by supportive policies and increased funding. As regulatory landscapes evolve, they impact market entry and expansion strategies. The competitive benchmarking highlights the importance of compliance, innovation, and strategic collaborations in sustaining market leadership.

Geographical Overview:

The CRISPR market is witnessing remarkable growth across various regions, each exhibiting unique dynamics. North America leads the market due to robust research initiatives and substantial funding from both public and private sectors. The region's strong biotechnology infrastructure and supportive regulatory environment further bolster its dominance. Europe follows closely, driven by significant investments in genetic research and a favorable regulatory framework that encourages innovation. Asia Pacific is emerging as a lucrative growth pocket, fueled by increasing governmental support and rising investments in biotechnology. Countries like China and Japan are at the forefront, leveraging their technological prowess to advance CRISPR applications. In Latin America, Brazil is making strides, with growing research activities and collaborations enhancing its market potential. The Middle East & Africa are gradually recognizing CRISPR's potential, with countries like South Africa investing in genetic research to drive future growth.

Key Trends and Drivers:

The CRISPR market is rapidly expanding, driven by advancements in gene-editing technologies and increasing research activities. Key trends include the growing application of CRISPR in agriculture, where it is used to develop disease-resistant crops and improve yield. In the healthcare sector, CRISPR is revolutionizing treatments for genetic disorders, offering precise and efficient solutions. The rise in biotechnology investments is a significant driver, with companies seeking innovative applications of CRISPR technology. Regulatory support and favorable government policies are also boosting market growth. Additionally, collaborations between academic institutions and biotech firms are accelerating research and development efforts. Opportunities abound in personalized medicine, where CRISPR can tailor treatments to individual genetic profiles. The market is also witnessing increased interest in CRISPR-based diagnostics, which promise rapid and accurate disease detection. As ethical considerations are addressed, the CRISPR market is poised for sustained growth, driven by its transformative potential across various sectors.

Restraints and Challenges:

The CRISPR market is currently navigating a landscape of significant restraints and challenges. A prominent restraint is the ethical concerns surrounding gene editing, which hinder regulatory approvals and public acceptance. These concerns are amplified by the potential for unintended genetic consequences, necessitating rigorous oversight and cautious application. Another challenge is the high cost associated with CRISPR technology, which can be prohibitive for small-scale research institutions and developing regions. This financial barrier restricts access and slows the pace of innovation. Additionally, intellectual property disputes over CRISPR patents create legal complexities and can impede collaborative research efforts. The market also faces technical challenges, such as off-target effects, which compromise the precision of gene editing. These technical hurdles demand extensive research and development to ensure safety and efficacy. Lastly, the rapid evolution of CRISPR technology necessitates continuous education and training for researchers, posing a challenge in keeping pace with advancements.

Key Players:

Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, Mammoth Biosciences, Beam Therapeutics, Synthego, Inscripta, Cellecta, Horizon Discovery, ToolGen, Egenesis, Graphite Bio, Locus Biosciences, Poseida Therapeutics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Genome Editing
    • 4.1.2 Gene Silencing
    • 4.1.3 Gene Amplification
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 CRISPR Kits
    • 4.2.2 CRISPR Libraries
    • 4.2.3 CRISPR Reagents
    • 4.2.4 CRISPR Plasmids
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom CRISPR Services
    • 4.3.2 Genetic Screening
    • 4.3.3 Cell Line Engineering
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR-Cas9
    • 4.4.2 CRISPR-Cas12
    • 4.4.3 CRISPR-Cas13
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Biomedical Research
    • 4.5.2 Agricultural Biotechnology
    • 4.5.3 Industrial Biotechnology
    • 4.5.4 Drug Development
    • 4.5.5 Diagnostics
    • 4.5.6 Therapeutics
    • 4.5.7 Gene Therapy
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Companies
    • 4.6.2 Biotechnology Companies
    • 4.6.3 Research Institutes
    • 4.6.4 Academic Institutions
    • 4.6.5 Contract Research Organizations
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Guide RNA
    • 4.7.2 Cas Enzymes
    • 4.7.3 Donor DNA Templates
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Gene Knockout
    • 4.8.2 Gene Knock-in
    • 4.8.3 Gene Regulation
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Off-the-shelf Solutions
    • 4.9.2 Customized Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Editas Medicine
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CRISPR Therapeutics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Intellia Therapeutics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Caribou Biosciences
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Mammoth Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Beam Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Synthego
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Inscripta
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Cellecta
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Horizon Discovery
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 ToolGen
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Egenesis
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Graphite Bio
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Locus Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Poseida Therapeutics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us